Clinical Trials in Baltimore

Showing 5321-5340 of 23,476 trials

CCT-102 or Expectant Management in Delayed Pregnancy Loss

NCT06121063

A Phase 3, multi-center clinical trial of a CCT-102 regimen or expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).

Early Pregnancy Loss, Delayed Pregnancy Loss

Conceptra Biosciences, LLC183 participantsStarted Jul 2023

Tucson, Arizona, United States • San Fernando, California, United States • Panama City, Florida, United States +12 more locations

RECRUITINGPhase 2< 1 mile

Study of JK07 in Patients With Chronic Heart Failure

NCT06369298

This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart failure. There will be 2 cohorts in this study: Cohort 1: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) of ≤ 40%. Cohort 2: Heart failure (HF) participants with left ventricular ejection fraction (LVEF) \> 40% and ≤ 65%.

Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction

Salubris Biotherapeutics Inc282 participantsStarted Mar 2024

Alexander City, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +59 more locations

CCT-102 or Expectant Management in Delayed Pregnancy Loss

Study of JK07 in Patients With Chronic Heart Failure

Find Trials by Condition in Baltimore

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

Study to Assess AFM24 in Combination With Atezolizumab in Selected Advanced/Metastatic EGFR-expressing Cancers

Near-infrared Spectroscopy and Electroencephalography to Assess Cortical Activation During Motor Tasks in Infants and Toddlers With and Without Cerebral Palsy

Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults

Intermediate-size Expanded Access to ONC201 for Patients With H3 K27M-mutant and/or Midline Gliomas

A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma

Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation

STICH3C Cardiac Magnetic Resonance Observational Study

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

A Study Assessing KB407 for the Treatment of Cystic Fibrosis

A Study to Evaluate the Effect of Ustekinumab on Cytochrome P450 Enzyme Activities Following Induction and Maintenance Dosing in Participants With Active Crohn's Disease or Ulcerative Colitis

Families Left Behind

Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies

Sickle Cell Disease, Hemechip

INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112)